Top compounds associated with response to GGTLC3


Feature Type Standardized
Nominal ANOVA
mRNA ML311 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA fingolimod CTRPv2 pan-cancer AAC 0.011 0.8
mRNA istradefylline CTRPv2 pan-cancer AAC -0.018 0.8
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.015 0.8
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC -0.012 0.8
mRNA hyperforin CTRPv2 pan-cancer AAC -0.012 0.8
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.0095 0.8
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
Download CSV